DAROLUTAMIDE for Prostate cancer: Side Effects & Safety Data
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
There are 990 adverse event reports in the FDA FAERS database where DAROLUTAMIDE was used for Prostate cancer.
Most Reported Side Effects for DAROLUTAMIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 384 | 11.8% | 11 | 62 |
| Death | 361 | 11.1% | 359 | 23 |
| Hot flush | 203 | 6.3% | 4 | 26 |
| Asthenia | 173 | 5.3% | 8 | 49 |
| Prostatic specific antigen increased | 156 | 4.8% | 9 | 23 |
| Off label use | 133 | 4.1% | 10 | 30 |
| Neuropathy peripheral | 127 | 3.9% | 0 | 12 |
| Diarrhoea | 122 | 3.8% | 4 | 25 |
| Dizziness | 122 | 3.8% | 3 | 28 |
| Rash | 116 | 3.6% | 5 | 17 |
| Arthralgia | 115 | 3.5% | 3 | 22 |
| Nausea | 111 | 3.4% | 1 | 32 |
| Dyspnoea | 109 | 3.4% | 8 | 41 |
| Pain in extremity | 106 | 3.3% | 4 | 32 |
| Decreased appetite | 105 | 3.2% | 7 | 34 |
Other Indications for DAROLUTAMIDE
Hormone-refractory prostate cancer (553)
Hormone-dependent prostate cancer (294)
Prostate cancer metastatic (200)
Product used for unknown indication (193)
Metastases to bone (31)
Metastasis (18)
Metastases to lymph nodes (11)
Metastases to lung (9)
Prostate cancer stage iv (8)
Neoplasm malignant (6)
Other Drugs Used for Prostate cancer
LEUPROLIDE (45,399)
ENZALUTAMIDE (25,954)
RELUGOLIX (18,752)
ABIRATERONE (12,209)
APALUTAMIDE (3,286)
GOSERELIN (2,080)
DEGARELIX (2,035)
BICALUTAMIDE (1,832)
SIPULEUCEL-T (1,720)
DENOSUMAB (1,627)